{
    "startDate": "2017-01-01",
    "endDate": "2017-12-31",
    "year": "2017",
    "quarter": "FY",
    "symbol": "INO",
    "data": {
        "bs": [
            {
                "label": "Cash and cash equivalents",
                "concept": "CashAndCashEquivalentsAtCarryingValue",
                "unit": "usd",
                "value": 23786579
            },
            {
                "label": "Short-term investments",
                "concept": "ShortTermInvestments",
                "unit": "usd",
                "value": 103638844
            },
            {
                "label": "Accounts receivable",
                "concept": "AccountsReceivableNetCurrent",
                "unit": "usd",
                "value": 6003205
            },
            {
                "label": "Accounts receivable from affiliated entities",
                "concept": "AccountsReceivableRelatedPartiesCurrent",
                "unit": "usd",
                "value": 486619
            },
            {
                "label": "Prepaid expenses and other current assets",
                "concept": "PrepaidExpenseAndOtherAssetsCurrent",
                "unit": "usd",
                "value": 2600906
            },
            {
                "label": "Prepaid expenses and other current assets from affiliated entities",
                "concept": "ino:PrepaidExpensesAndOtherCurrentAssetsFromAffiliatedEntity",
                "unit": "usd",
                "value": 1846007
            },
            {
                "label": "Current assets:",
                "concept": "AssetsCurrent",
                "unit": "usd",
                "value": 138362160
            },
            {
                "label": "Fixed assets, net",
                "concept": "PropertyPlantAndEquipmentNet",
                "unit": "usd",
                "value": 18320176
            },
            {
                "label": "Investment in affiliated entity - GeneOne",
                "concept": "InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures",
                "unit": "usd",
                "value": 9069401
            },
            {
                "label": "Investment in affiliated entity - PLS",
                "concept": "CostMethodInvestmentsFairValueDisclosure",
                "unit": "usd",
                "value": 2325079
            },
            {
                "label": "Intangible assets, net",
                "concept": "IntangibleAssetsNetExcludingGoodwill",
                "unit": "usd",
                "value": 6009729
            },
            {
                "label": "Goodwill",
                "concept": "Goodwill",
                "unit": "usd",
                "value": 10513371
            },
            {
                "label": "Other assets",
                "concept": "OtherAssetsNoncurrent",
                "unit": "usd",
                "value": 2639354
            },
            {
                "label": "ASSETS",
                "concept": "Assets",
                "unit": "usd",
                "value": 187239270
            },
            {
                "label": "Accounts payable and accrued expenses",
                "concept": "AccountsPayableAndAccruedLiabilitiesCurrent",
                "unit": "usd",
                "value": 23278798
            },
            {
                "label": "Accounts payable and accrued expenses due to affiliated entities",
                "concept": "DueToRelatedPartiesCurrent",
                "unit": "usd",
                "value": 926943
            },
            {
                "label": "Accrued clinical trial expenses",
                "concept": "AccruedLiabilitiesCurrent",
                "unit": "usd",
                "value": 8611892
            },
            {
                "label": "Common stock warrants",
                "concept": "WarrantsAndRightsOutstanding",
                "unit": "usd",
                "value": 360795
            },
            {
                "label": "Deferred revenue",
                "concept": "DeferredRevenueCurrent",
                "unit": "usd",
                "value": 1175353
            },
            {
                "label": "Deferred revenue from affiliated entities",
                "concept": "ino:DeferredRevenueFromAffiliatedEntityCurrent",
                "unit": "usd",
                "value": 174110
            },
            {
                "label": "Deferred rent",
                "concept": "DeferredRentCreditCurrent",
                "unit": "usd",
                "value": 877535
            },
            {
                "label": "Current liabilities:",
                "concept": "LiabilitiesCurrent",
                "unit": "usd",
                "value": 35405426
            },
            {
                "label": "Deferred revenue, net of current portion",
                "concept": "DeferredRevenueNoncurrent",
                "unit": "usd",
                "value": 215853
            },
            {
                "label": "Deferred revenue from affiliated entities, net of current portion",
                "concept": "ino:DeferredRevenueFromAffiliatedEntityNoncurrent",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "Deferred rent, net of current portion",
                "concept": "DeferredRentCreditNoncurrent",
                "unit": "usd",
                "value": 9104416
            },
            {
                "label": "Deferred tax liabilities",
                "concept": "DeferredIncomeTaxLiabilitiesNet",
                "unit": "usd",
                "value": 24766
            },
            {
                "label": "LIABILITIES AND STOCKHOLDERS\u2019 EQUITY",
                "concept": "Liabilities",
                "unit": "usd",
                "value": 44750461
            },
            {
                "label": "Commitments and contingencies",
                "concept": "CommitmentsAndContingencies",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Preferred stock\u2014par value $0.001; Authorized shares: 10,000,000, issued and outstanding shares: 23 at December 31, 2017 and December 31, 2016",
                "concept": "PreferredStockValue",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "Common stock\u2014par value $0.001; Authorized shares: 600,000,000 at December 31, 2017 and December 31, 2016, issued and outstanding: 90,357,644 at December 31, 2017 and 74,062,370 at December 31, 2016",
                "concept": "CommonStockValue",
                "unit": "usd",
                "value": 90358
            },
            {
                "label": "Additional paid-in capital",
                "concept": "AdditionalPaidInCapital",
                "unit": "usd",
                "value": 665775504
            },
            {
                "label": "Accumulated deficit",
                "concept": "RetainedEarningsAccumulatedDeficit",
                "unit": "usd",
                "value": -523356317
            },
            {
                "label": "Accumulated other comprehensive income (loss)",
                "concept": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
                "unit": "usd",
                "value": -117005
            },
            {
                "label": "Stockholders' Equity Note [Abstract]",
                "concept": "StockholdersEquity",
                "unit": "usd",
                "value": 142392540
            },
            {
                "label": "Non-controlling interest",
                "concept": "MinorityInterest",
                "unit": "usd",
                "value": 96269
            },
            {
                "label": "Total stockholders\u2019 equity",
                "concept": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
                "unit": "usd",
                "value": 142488809
            },
            {
                "label": "LIABILITIES AND STOCKHOLDERS\u2019 EQUITY",
                "concept": "LiabilitiesAndStockholdersEquity",
                "unit": "usd",
                "value": 187239270
            }
        ],
        "cf": [
            {
                "label": "Net loss",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": -88205772
            },
            {
                "label": "Depreciation",
                "concept": "Depreciation",
                "unit": "usd",
                "value": 1850376
            },
            {
                "label": "Amortization of intangible assets",
                "concept": "AmortizationOfIntangibleAssets",
                "unit": "usd",
                "value": 1618665
            },
            {
                "label": "Change in value of common stock warrants",
                "concept": "ino:ChangeInValueOfCommonStockWarrants",
                "unit": "usd",
                "value": -806819
            },
            {
                "label": "Equity Award [Domain]",
                "concept": "ShareBasedCompensation",
                "unit": "usd",
                "value": 13070962
            },
            {
                "label": "Amortization of premiums on investments",
                "concept": "InvestmentIncomeAmortizationOfPremium",
                "unit": "usd",
                "value": 319845
            },
            {
                "label": "Deferred taxes",
                "concept": "IncreaseDecreaseInDeferredIncomeTaxes",
                "unit": "usd",
                "value": 150027
            },
            {
                "label": "Deferred rent",
                "concept": "StraightLineRent",
                "unit": "usd",
                "value": -3608881
            },
            {
                "label": "Loss on short-term investments",
                "concept": "ino:ImpairmentOfLongTermInvestments",
                "unit": "usd",
                "value": 215423
            },
            {
                "label": "Gain on investment in affiliated entity",
                "concept": "ino:ChangeInValueOfInvestmentsInAffiliatedCompany",
                "unit": "usd",
                "value": -6982664
            },
            {
                "label": "Gain on sale of intangible assets",
                "concept": "GainLossOnDispositionOfIntangibleAssets",
                "unit": "usd",
                "value": 1000000
            },
            {
                "label": "Income tax benefit from other unrealized gains on securities",
                "concept": "ino:UnrealizedGainOnInvestmentsIncomeTaxBenefit",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "Accounts receivable",
                "concept": "IncreaseDecreaseInAccountsReceivable",
                "unit": "usd",
                "value": -9818306
            },
            {
                "label": "Accounts receivable from affiliated entity",
                "concept": "IncreaseDecreaseInAccountsReceivableRelatedParties",
                "unit": "usd",
                "value": -261736
            },
            {
                "label": "Prepaid expenses and other current assets",
                "concept": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
                "unit": "usd",
                "value": 851847
            },
            {
                "label": "Prepaid expenses and other current assets from affiliated entity",
                "concept": "ino:IncreaseDecreaseInPrepaidExpensesAndOtherCurrentAssetsFromAffiliatedEntity",
                "unit": "usd",
                "value": 333583
            },
            {
                "label": "Other assets",
                "concept": "IncreaseDecreaseInOtherOperatingAssets",
                "unit": "usd",
                "value": 526207
            },
            {
                "label": "Accounts payable and accrued expenses",
                "concept": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities",
                "unit": "usd",
                "value": 2829807
            },
            {
                "label": "Accrued clinical trial expenses",
                "concept": "IncreaseDecreaseInAccruedLiabilities",
                "unit": "usd",
                "value": 2243503
            },
            {
                "label": "Accounts payable and accrued expenses due to affiliated entity",
                "concept": "IncreaseDecreaseInAccountsPayableRelatedParties",
                "unit": "usd",
                "value": -145636
            },
            {
                "label": "Deferred revenue",
                "concept": "IncreaseDecreaseInDeferredRevenue",
                "unit": "usd",
                "value": -13689322
            },
            {
                "label": "Deferred revenue from affiliated entity",
                "concept": "ino:IncreaseDecreaseInDeferredRevenueFromRelatedParties",
                "unit": "usd",
                "value": -319876
            },
            {
                "label": "Cash flows from operating activities:",
                "concept": "NetCashProvidedByUsedInOperatingActivities",
                "unit": "usd",
                "value": -63208921
            },
            {
                "label": "Purchases of investments",
                "concept": "PaymentsToAcquireShortTermInvestments",
                "unit": "usd",
                "value": 95700144
            },
            {
                "label": "Maturities of investments",
                "concept": "ProceedsFromSaleOfShortTermInvestments",
                "unit": "usd",
                "value": 77162902
            },
            {
                "label": "Purchases of capital assets",
                "concept": "PaymentsToAcquirePropertyPlantAndEquipment",
                "unit": "usd",
                "value": 10293902
            },
            {
                "label": "Full payment",
                "concept": "ProceedsFromSaleOfIntangibleAssets",
                "unit": "usd",
                "value": 1000000
            },
            {
                "label": "Purchase of intangible and other assets",
                "concept": "PaymentsToAcquireIntangibleAssets",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "Cash flows from investing activities:",
                "concept": "NetCashProvidedByUsedInInvestingActivities",
                "unit": "usd",
                "value": -27831144
            },
            {
                "label": "Proceeds from issuance of common stock",
                "concept": "ProceedsFromIssuanceOfCommonStock",
                "unit": "usd",
                "value": 94347922
            },
            {
                "label": "Proceeds from stock option and warrant exercises, net of tax payments",
                "concept": "ino:ProceedsfromStockOptionandWarrantExercises",
                "unit": "usd",
                "value": 1342250
            },
            {
                "label": "Expenses from other financing activities",
                "concept": "ProceedsFromPaymentsForOtherFinancingActivities",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "Cash flows from financing activities:",
                "concept": "NetCashProvidedByUsedInFinancingActivities",
                "unit": "usd",
                "value": 95690172
            },
            {
                "label": "Increase (Decrease) in cash and cash equivalents",
                "concept": "CashAndCashEquivalentsPeriodIncreaseDecrease",
                "unit": "usd",
                "value": 4650107
            },
            {
                "label": "Common stock issued for purchase of Bioject",
                "concept": "ino:CommonStockIssuedForIntangibleAndOtherAssets",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "Change in amounts accrued for purchases of property and equipment",
                "concept": "CapitalExpendituresIncurredButNotYetPaid",
                "unit": "usd",
                "value": 851204
            }
        ],
        "ic": [
            {
                "label": "Net loss",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": -88205772
            },
            {
                "label": "Unrealized gain (loss) on investment in affiliated entity, net of tax",
                "concept": "ino:OtherComprehensiveIncomeLossUnrealizedGainLossOnInvestmentInAffiliatedEntityNetOfTax",
                "unit": "usd",
                "value": -1452431
            },
            {
                "label": "Unrealized gain (loss) on short-term investments, net of tax",
                "concept": "OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax",
                "unit": "usd",
                "value": 7458
            },
            {
                "label": "Comprehensive loss",
                "concept": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
                "unit": "usd",
                "value": -89650745
            },
            {
                "label": "Comprehensive income attributable to non-controlling interest",
                "concept": "ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "Comprehensive loss",
                "concept": "ComprehensiveIncomeNetOfTax",
                "unit": "usd",
                "value": -89650745
            },
            {
                "label": "Revenue under collaborative research and development arrangements",
                "concept": "ino:RevenueUnderCollaborativeResearchandDevelopmentArrangements",
                "unit": "usd",
                "value": 28407388
            },
            {
                "label": "Revenue under collaborative research and development arrangements with affiliated entities",
                "concept": "ino:RevenueUnderCollaborativeResearchAndDevelopmentArrangementsWithAffiliatedEntity",
                "unit": "usd",
                "value": 765828
            },
            {
                "label": "Grants and miscellaneous revenue",
                "concept": "RevenueFromGrants",
                "unit": "usd",
                "value": 10474539
            },
            {
                "label": "Grants and miscellaneous revenue from affiliated entity",
                "concept": "RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty",
                "unit": "usd",
                "value": 2572331
            },
            {
                "label": "Revenues:",
                "concept": "Revenues",
                "unit": "usd",
                "value": 42220086
            },
            {
                "label": "Research and Development Expense",
                "concept": "ResearchAndDevelopmentExpense",
                "unit": "usd",
                "value": 98572618
            },
            {
                "label": "General and Administrative Expense",
                "concept": "GeneralAndAdministrativeExpense",
                "unit": "usd",
                "value": 28290369
            },
            {
                "label": "Gain on sale of intangible assets",
                "concept": "GainLossOnDispositionOfIntangibleAssets",
                "unit": "usd",
                "value": 1000000
            },
            {
                "label": "Operating expenses:",
                "concept": "OperatingExpenses",
                "unit": "usd",
                "value": 125862987
            },
            {
                "label": "Loss from operations",
                "concept": "OperatingIncomeLoss",
                "unit": "usd",
                "value": -83642901
            },
            {
                "label": "Interest and other income, net",
                "concept": "InterestAndOtherIncome",
                "unit": "usd",
                "value": 1612974
            },
            {
                "label": "Change in fair value of common stock warrants",
                "concept": "ino:ChangeInFairValueOfCommonStockWarrants",
                "unit": "usd",
                "value": 806819
            },
            {
                "label": "Gain on investment in affiliated entity",
                "concept": "ino:ChangeInValueOfInvestmentsInAffiliatedCompany",
                "unit": "usd",
                "value": -6982664
            },
            {
                "label": "Net loss before income tax benefit",
                "concept": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
                "unit": "usd",
                "value": -88205772
            },
            {
                "label": "Income Tax Expense (Benefit), Continuing Operations, Income Tax Reconciliation [Abstract]",
                "concept": "IncomeTaxExpenseBenefit",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "Net income attributable to non-controlling interest",
                "concept": "NetIncomeLossAttributableToNoncontrollingInterest",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "Net loss attributable to Inovio Pharmaceuticals, Inc.",
                "concept": "NetIncomeLoss",
                "unit": "usd",
                "value": -88205772
            },
            {
                "label": "Basic ($ per share)",
                "concept": "EarningsPerShareBasic",
                "unit": "usd/shares",
                "value": -1.08
            },
            {
                "label": "Net loss per share, Diluted ($ per share)",
                "concept": "EarningsPerShareDiluted",
                "unit": "usd/shares",
                "value": -1.09
            },
            {
                "label": "Weighted average number of common shares outstanding (shares)",
                "concept": "WeightedAverageNumberOfSharesOutstandingBasic",
                "unit": "shares",
                "value": 81777493
            },
            {
                "label": "Denominator for use in diluted loss per share (shares)",
                "concept": "WeightedAverageNumberOfDilutedSharesOutstanding",
                "unit": "shares",
                "value": 81918022
            }
        ]
    }
}